WADA announces self-suspension of the Helsinki Laboratory
The World Anti-Doping Agency (WADA) announces that the Doping Control Laboratory in Helsinki, Finland (Helsinki Laboratory) has advised WADA that it wishes to self-suspend its anti-doping activities while it finalizes its plan to re-locate to a new facility, under a new host organization.
Accordingly, WADA has agreed to suspend the Helsinki Laboratory’s accreditation, effective 15 February 2019; and, during the period of suspension, the Laboratory will not be able to carry out any analyses of urine and/or blood samples for anti-doping purposes.
The Stockholm Laboratory / Foto: ©Karolinska
As the Helsinki Laboratory’s suspension is not related to an analytical or compliance issue, it may apply for reinstatement once the transfer to a new location and host organization is completed; and, once it has met stipulated conditions to restart operations in accordance with the International Standard for Laboratories (ISL) and its related Technical Documents.
MORE ON: https://www.wada-ama.org/en/media/news/2019-02/wada-announces-self-suspension-of-the-helsinki-laboratory AUTHOR: WADA SOURCE: wada-ama.org PUBLISHED: February 13, 2019